Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

Completed · Not applicable

Conditions studied: Coronary Artery Disease

In brief

1. The MyoVista device is capable of detecting surface electrocardiogram signals and sensitive in detecting coronary artery disease compared to traditional computed tomography angiography (CTA) 2. Electrophysiological signals at the cellular level of myocardium are related to specific patterns on the MyoVista device 3. Changes in MyoVista device output and can indicative of future CAD outcomes and need for revascularization

Key facts

Study ID

NCT02560168

Run by

Icahn School of Medicine at Mount Sinai

People needed

200

Starts

2015-10-01

Expected to finish

2016-06-01

Last updated by the study team

2017-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Sinus rhythms
• Age>18 years
• Both genders

You may not qualify if…

• Acute coronary syndromes(ACS)
• Contraindications to the administration of iodinated contrast
• Pregnancy
• Coronary artery bypass surgery (CABG)
• History of cardiac valvular replacement
• Implanted cardiac pacemaker
• Chest deformities
• Unwilling or unable to provide informed consent for study participation
• Enrolled in another clinical study

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.